247 related articles for article (PubMed ID: 34049521)
21. The antiosteoporotic activity of central-icaritin (CIT) on bone metabolism of ovariectomized rats.
Jiang J; Li J; Jia X
Molecules; 2014 Nov; 19(11):18690-704. PubMed ID: 25405287
[TBL] [Abstract][Full Text] [Related]
22. Effect of Morinda officinalis capsule on osteoporosis in ovariectomized rats.
Li Y; Lü SS; Tang GY; Hou M; Tang Q; Zhang XN; Chen WH; Chen G; Xue Q; Zhang CC; Zhang JF; Chen Y; Xu XY
Chin J Nat Med; 2014 Mar; 12(3):204-12. PubMed ID: 24702807
[TBL] [Abstract][Full Text] [Related]
23. Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis.
Devareddy L; Hooshmand S; Collins JK; Lucas EA; Chai SC; Arjmandi BH
J Nutr Biochem; 2008 Oct; 19(10):694-9. PubMed ID: 18328688
[TBL] [Abstract][Full Text] [Related]
24. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
[TBL] [Abstract][Full Text] [Related]
25. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.
Mok SK; Chen WF; Lai WP; Leung PC; Wang XL; Yao XS; Wong MS
Br J Pharmacol; 2010 Feb; 159(4):939-49. PubMed ID: 20128811
[TBL] [Abstract][Full Text] [Related]
26. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
[TBL] [Abstract][Full Text] [Related]
27. The time-dependent effect of ibandronate on bone graft remodeling in an ovariectomized rat spinal arthrodesis model.
Park SB; Park SH; Kang YK; Chung CK
Spine J; 2014 Aug; 14(8):1748-57. PubMed ID: 24486470
[TBL] [Abstract][Full Text] [Related]
28. Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats.
Xu M; Dick IM; Day R; Randall D; Prince RL
Am J Chin Med; 2003; 31(1):87-101. PubMed ID: 12723758
[TBL] [Abstract][Full Text] [Related]
29. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
Komm BS; Vlasseros F; Samadfam R; Chouinard L; Smith SY
Bone; 2011 Sep; 49(3):376-86. PubMed ID: 21658483
[TBL] [Abstract][Full Text] [Related]
30. Dual-energy x-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss.
Griffin MG; Kimble R; Hopfer W; Pacifici R
J Bone Miner Res; 1993 Jul; 8(7):795-800. PubMed ID: 8352062
[TBL] [Abstract][Full Text] [Related]
31. Treatment of osteoporosis with TheraCyte-encapsulated parathyroid cells: a study in a rat model.
Chou FF; Huang SC; Chen SS; Wang PW; Huang PH; Lu KY
Osteoporos Int; 2006; 17(6):936-41. PubMed ID: 16596462
[TBL] [Abstract][Full Text] [Related]
32. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
[TBL] [Abstract][Full Text] [Related]
33. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis.
Devareddy L; Khalil DA; Smith BJ; Lucas EA; Soung do Y; Marlow DD; Arjmandi BH
Bone; 2006 May; 38(5):686-93. PubMed ID: 16406762
[TBL] [Abstract][Full Text] [Related]
34. Skeletal site-specific response to ovariectomy in a rat model: change in bone density and microarchitecture.
Liu XL; Li CL; Lu WW; Cai WX; Zheng LW
Clin Oral Implants Res; 2015 Apr; 26(4):392-398. PubMed ID: 24593016
[TBL] [Abstract][Full Text] [Related]
35. Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats.
Zhang R; Hu SJ; Li C; Zhang F; Gan HQ; Mei QB
J Ethnopharmacol; 2012 Jan; 139(1):12-8. PubMed ID: 21669273
[TBL] [Abstract][Full Text] [Related]
36. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
37. Vitamin K3 increased BMD at 1 and 2 months post-surgery and the maximum stress of the middle femur in the rat.
Hong YJ; Liu S; Jiang NY; Jiang S; Liang JG
Nutr Res; 2015 Feb; 35(2):155-61. PubMed ID: 25433907
[TBL] [Abstract][Full Text] [Related]
38. Combined Effects of Phytoestrogen Genistein and Silicon on Ovariectomy-Induced Bone Loss in Rat.
Qi S; Zheng H
Biol Trace Elem Res; 2017 Jun; 177(2):281-287. PubMed ID: 27785742
[TBL] [Abstract][Full Text] [Related]
39. Effect of weight manipulation on bone loss due to ovariectomy and the protective effects of estrogen in the rat.
Roudebush RE; Magee DE; Benslay DN; Bendele AM; Bryant HU
Calcif Tissue Int; 1993 Jul; 53(1):61-4. PubMed ID: 8348385
[TBL] [Abstract][Full Text] [Related]
40. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Arshad M; Sengupta S; Sharma S; Ghosh R; Sawlani V; Singh MM
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):67-78. PubMed ID: 15261309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
